You are here
China's Tasly to list biotech arm in HK
CHINA'S Tasly Pharmaceutical Group is planning to list its biopharma unit in Hong Kong to raise about US$1 billion, in what is likely to be the largest biotech float in the city this year, people with knowledge of the matter said.
The plan comes as Hong Kong Exchanges and
- CALL +65 6388 3838
- EMAIL email@example.com